Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 3, 1995, Pages 922-926

  Imagawa, Akihisa ^a   Itoh, Naoto ^a   Hanafusa, Toshiaki ^a   Oda, Yasuo ^a   Waguri, Masako ^a   Miyagawa, Jun Ichiro ^a   Kono, Norio ^a   Kuwajima, Masamichi ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL ANTIBODY; HEMOGLOBIN A1C; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; MUSCLE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PARIETAL CELL ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY;

ADRENAL MEDULLA; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHRONIC ACTIVE HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; THYROID FUNCTION TEST;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; THYROID GLAND;

HEPATITIS C VIRUS;

EID: 0028941761     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.3.7883851     Document Type: Article

References (23)

1. Baron S, Tyring SK, Fleischmann Jr WR, et al. 1991 The interferons. JAMA. 266:1375-1383.
2. Burman P, Tötterman TH, Öberg K, Karlsson FA. 1986 Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab. 63:1086-1090.
3. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. 1992 Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology. 102:2155-2160.
4. Gisslinger H, Gilly B, Woloszczuk W, et al. 1992 Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol. 90:363-367.
5. Fabris P, Betlerle C, Floreani A, et al. 1992 Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet. 340:548.
6. Waguri M, Hanafusa T, Itoh N, et al. 1994 Occurrence of 1DDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract. 23:33-36.
7. DeGroot LJ, Quintans J. 1989 The causes of autoimmune thyroid disease. Endocr Rev. 10:537-562.
8. Eisenbarth GS. 1986 Type 1 diabetes melLitus. A chronic autoimmune disease. N Engl J Med. 314:1360-1368.
9. Rönnblom LE, Aim G V, Öberg KE. 1991 Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med. 115:178-183
10. Mayet WJ, Hess G, Gerken G, et al. 1989 Treatment of chronic type B hepatitis with recombinant a-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology. 10: 24-28.
11. Saracco G, Touscoz A, Durazzo M, et al. 1990 Autoantibodies and response to a-interferon in patients with chronic viral hepatitis. J Hepatol. 11:339-343.
12. Bottazzo GF, Florin-Christensen A, Doniach D. 1974 Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 2:1279-1282.
13. Shindo M, Di Blchglie AM, Hoofnagle JH. 1992 Long-term fol-low-up of patients with chronic hepatitis C treated with a-interferon. Hepatology. 15:1013-1016.
14. Itoh N, Hanafusa T, Katsura H, et al. 1991 Two types of autoantibodies to adrenal medullary cells in type 1 (insulin-dependent) diabetic patients: prevalence, properties and implications. J Autoimmunity. 4:807-818.
15. Beever K, Bradbury J, Phillips D, et al. 1989 Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem. 35:1949-1954.
16. Foulis AK, Farquharson MA, Meager A. 1987 Immunoreactive a-interferon in insulin-secreting ?? cells in type 1 diabetes mellitus. Lancet. 2:1423-1427.
17. Foulis AK, Jackson R, Farquharson MA. 1988 The pancreas in idiopathic Addison’s disease-a search for a prediabetic pancreas. Histopathology. 12:481-490.
18. Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF. 1986 Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol. 65:128-139.
19. Koivisto VA, Pelkonen R, Cantell K. 1989 Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 38:641-647.
20. Kolaczynski JW, Taskinen MR, Hilden H, Kiviluoto T, Cantell K, Koivisto VA. 1992 Effects of interferon alpha on insulin binding and glucose transport in human adipocytes. Eur J Clin Invest. 22: 292-299.
21. Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. 1976 Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 29; 403-410.
22. Popper H, Schaffner F. 1970 Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog Liver Dis. 3:336-354.
23. Silva MO, Rajender Reddy K, Jeffers LJ, Hill M, Schiff ER. 1991 Interferon-induced chronic active hepatitis? Gastroenterology. 101: 840-842.